Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach

home / publications / supplement / 1998-04-vol4-n4suppl

Participating Faculty

ArticleSUPPLEMENT CONTENT

Introduction: Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach

ArticleSUPPLEMENT CONTENT

Coronary Heart Disease in the United States

Grant D. Lawless, MD

ArticleSUPPLEMENT CONTENT

Mechanisms of Acute Coronary Events

Daniel J. Rader, MD

ArticleSUPPLEMENT CONTENT

Primary Prevention

Stuart M. Cobbe, MD

ArticleSUPPLEMENT CONTENT

Pravastatin Event Reduction Analysis

James Shepherd, MD, PhD

ArticleSUPPLEMENT CONTENT

Secondary Prevention

John S. Banas, Jr., MD

ArticleSUPPLEMENT CONTENT

Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?

William P. Castelli, MD;W. Virgil Brown, MD;Evan A. Stein, MD, PhD;James Shepherd, MD, PhD

ArticleSUPPLEMENT CONTENT

Methods and Mindsets in Pharmacoeconomics

William F. McGhan, PharmD, PhD

ArticleSUPPLEMENT CONTENT

Issues and Controversies in Pharmacoeconomics

William F. McGhan, PharmD, PhD;James M. McKenney, PharmD;Susan Andrade, ScD;Sidney C. Smith, Jr, MD;Bruce Kinosian, MD;Joel W. Hay, PhD

ArticleSUPPLEMENT CONTENT

Pharmacoeconomics Perspectives: Payers, Providers, and Patients

Paul C. Langley, PhD;Nicolaas Otten, PharmD;Peter Davey, MD;James C. Bonnette, MD;J. Russell Teagarden;William F. McGhan, PharmD, PhD

ArticleSUPPLEMENT CONTENT

Assessing the Value and Affordability of Cholesterol Reduction in the Managed Care Setting

Edgar R. Gonzalez, PharmD;Barbara S. Kannewurf, RPh

ArticleCONTINUING MEDICAL EDUCATION

ArticleSUPPLEMENT CONTENT

Selected Abstracts

ArticleSUPPLEMENT CONTENT

ArticleSUPPLEMENT CONTENT

Part I: Scope of the Problem

ArticleSUPPLEMENT CONTENT

Part II: Primary Prevention

ArticleSUPPLEMENT CONTENT

Part III: Secondary Prevention

ArticleSUPPLEMENT CONTENT

Part IV: Pharmacoeconomics

ArticleSUPPLEMENT CONTENT

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences
AJMC®
All rights reserved.